AbbVie Bid for Biotech Could Expand with Experimental Drug
AbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
This guide clarifies which investors benefit most from target date funds versus index funds, focusing on goals and involvement level.
26,623 articlesAbbVie is exploring a cash purchase of about $10.9 billion for a biotech developing an experimental eczema drug, a mo...
A 64-year-old investor with a traditional IRA totaling $1.1 million pivots to three Dividend Kings to weather renewed...
Microsoft cutting 4,800 jobs marks a bold pivot toward AI and cloud infrastructure. The move comes with a hefty capex...
A surge in Wrapped Bitcoin (WBTC) exchange withdrawals reached a six-week peak, prompting traders to debate whether w...
Fuel shortages and rolling blackouts push Cuba toward a tipping point as sanctions tighten Venezuelan oil shipments. ...
New data shows high-end metro areas are turning over listings faster than mid-priced markets, upending expectations a...
Ethereum, XRP, Cardano, Binance Coin, and HYPE are drifting near critical levels as March market conditions unfold. T...
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Commercial Metals posted a blowout quarter in Q2 2026, with revenue hitting $2.132 billion and net income of $93 mill...
Ripple is in focus as XRP moves past a key resistance level amid upbeat market conditions. Analysts describe a potent...
A timely look at how george kamel’s message couples shapes decisions on budgeting and investing as households navigat...
Dogecoin has fallen under the 10-cent threshold amid a broad risk-off in crypto markets. With no single catalyst, tra...